PharmaCyte Biotech Announces Pre-IND Meeting Date with FDA

PharmaCyte Biotech Announces Pre-IND Meeting Date with FDA

PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , today announced that it will be meeting with the Center for Biologics Evaluation and Research of the U.S. Food and Drug Administration on Tuesday, January 17, 2017. The meeting is to discuss numerous aspects of PharmaCyte's planned clinical trial in locally advanced, inoperable pancreatic cancer .

from Biotech News